Advertisement
First U.S. cost-effectiveness analysis in decades supports more surgical evaluations
New research elucidates key role of WISP1 protein
$2 million will enable preclinical dose and efficacy testing of “compound 3”
Acute symptomatic seizures detected in five of 22 patients monitored
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Depressed patients also have increased odds for new brain lesions on MRI
No actionable pathology was missed in large patient series
Researchers hope it will lead to earlier, more accurate diagnosis
$2M NIH grant will help see if dual-action agent lengthens treatment window
Researchers pair postmortem MRI with histopathology to explore thalamic atrophy
Odds of seizure freedom diminish with each additional operation
Advertisement
Advertisement